Literature DB >> 22918223

Contra: "Antidotes for novel anticoagulants?"--Do we really need them.

Elise S Eerenberg1, Marcel Levi, Harry R Büller.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 22918223     DOI： 10.1160/TH12-05-0298

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN： 0340-6245            Impact factor:   5.249


× No keyword cloud information.
  3 in total

Review 1.  Universal, class-specific and drug-specific reversal agents for the new oral anticoagulants.

Authors:  Jack E Ansell
Journal:  J Thromb Thrombolysis       Date:  2016-02       Impact factor: 2.300

2.  Single-dose ciraparantag safely and completely reverses anticoagulant effects of edoxaban.

Authors:  Jack E Ansell; Sasha H Bakhru; Bryan E Laulicht; Solomon S Steiner; Michael A Grosso; Karen Brown; Victor Dishy; Hans J Lanz; Michele F Mercuri; Robert J Noveck; James C Costin
Journal:  Thromb Haemost       Date:  2016-11-17       Impact factor: 5.249

Review 3.  Management of bleeding in patients treated with direct oral anticoagulants.

Authors:  Marcel Levi
Journal:  Crit Care       Date:  2016-08-20       Impact factor: 9.097
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.